Anti-Rheumatic Rx
![](https://pbs.twimg.com/profile_images/1625445768768135171/M24lCgC__normal.jpg)
9 months 3 weeks ago
#ACR23 Late-Breaking Abstr#L19 IA steroid can help osteoarthritis knee pain but effect & duration are variable. Phase 3 RCT: improvement in ADP & WOMAC pain favouring TLC5999 (liposomal modification of DEX) vs PBO at all timepoints inc. after repeated injection @RheumNow #ACRBest https://t.co/xUhoFHPExr
![](https://pbs.twimg.com/media/F-_TTZnXUAAL3gz.jpg)
![](https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg)
9 months 3 weeks ago
Would intraarticular steroids for knee OA be better with a sustained release formulation?
ph3, TLL599 (liposomal delivery dexamethasone) vs normal dex vs placebo
some gains over normal dex
well tolerated
New options always welcome in OA!
@ProfDavidHunter #ACR23 L19 @RheumNow https://t.co/TUrhppHMiD
![](https://pbs.twimg.com/media/F-_QkY1aAAAsgOt.jpg)
![](https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k_normal.jpg)
9 months 3 weeks ago
L20 #ACR23 @RheumNow
Telitacept - Recomb Fusion targets BlyS, APRIL in RA w inadeq MTX response
ACR 20 60% v 27% PBO (p<0.001), ACR 50 21% v 6% PBO (p<0.001)
DAS28-ESR <3.2 15% v 5%, reduct -1.6 v -1.0
Better PROs, less jt damage prog at w24
Safety SAE 6.4 v 6.7%, no ifn signal https://t.co/PsA6AxUHVW
![](https://pbs.twimg.com/media/F-_UN2eWwAAA651.png)
![](https://pbs.twimg.com/profile_images/1324821320429981703/dAiq_hpT_normal.jpg)
9 months 3 weeks ago
Sustained relief for knee OA
TLC599 - liposomal formulation of dexamethasone sodium phosphate
Single injection provided relief for 24 weeks, repeat injection with benefit up to wk 52
@RheumNow #ACR23 Abs#L19
#ACRBest https://t.co/BNGb3nHw8C
![](https://pbs.twimg.com/media/F-8HU39XMAAR-_a.png)
![](https://pbs.twimg.com/profile_images/1625445768768135171/M24lCgC__normal.jpg)
9 months 3 weeks ago
#ACR23 Late-Breaking Abstr#L20 Phase 3 RCT in China: Telitacicept (BAFF-APRIL-i) in MTX-IR #RA met ACR20 response vs PBO.
+ve: less radiographic damage
-ve: lower rate ACR50 (21%), homogenous population, no H2H active comparator
Unclear its place in current Mx @RheumNow https://t.co/SAc4B1aRD1
![](https://pbs.twimg.com/media/F-_XWrDWoAAaQi_.jpg)
![](https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg)
9 months 3 weeks ago
Telitacicept (BlyS/APRIL inhibitor) in MTX-IR RA. Phase 3 RCT. 479 patients. ACR20 60.0% vs 26.9%. ACR50 21.4% vs. 5.9%. Radiographic benefit also. Safety looks ok. Abstr#L20 #ACR23 #ACRbest @RheumNow https://t.co/qcinGeRX2d https://t.co/SIKKW7xhwV
![](https://pbs.twimg.com/media/F-41506WoAA7WcO.jpg)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg)
9 months 3 weeks ago
#ACRbest Peter Merkel as Distinguished Investigator said Data are good.
Need data to develop questions, understand #vasculitis Hx of #vasculitis - great minds & drugs -
now challenged by funding and comparators
Session 15W127 #ACR23 @RheumNow @ACRheum https://t.co/5leIeLWZ6O
![](https://pbs.twimg.com/media/F-_dnBqaEAAfYoC.jpg)
![](https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg)
9 months 3 weeks ago
Tommasi et al. MTX (vs SSZ) lowers BP in RA in RCT. At 6 months, significant reduction in SBP (mean difference -4.0ยฑ10.8 mmHg, p=0.038), MAP (mean difference -4.3ยฑ17.9 mmHg, p=0.023). Abstr#2151 #ACR23 @RheumNow https://t.co/wAX3dCztxH https://t.co/mPG5TdeHTu
![](https://pbs.twimg.com/media/F-5D6kaXYAABF5W.png)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg)
9 months 3 weeks ago
#vasculitis clinical trials are accelerating. Need the right time - early studies have lessons learned re feasibility and design/endpoints #ACR23 @RheumNow @ACRheum Great lecture - P Merkel 15W127 great graphs of vasculitis developments https://t.co/YRdPiaflxY
![](https://pbs.twimg.com/media/F-_fTJMbwAA0X_N.jpg)
![](https://pbs.twimg.com/profile_images/1463469865382125579/asKzXYsY_normal.jpg)
9 months 3 weeks ago
Knee OA, to inject or not to inject: the great debate ๐ฃ
A thread๐๐ผ๐๐ผ๐๐ผ
Maglette Klotenburg argues in favor, with moderation
IA GC improves pain
Repetitive injections can be harmful
@RheumNow #ACR23 https://t.co/3p4UVLngpx
![](https://pbs.twimg.com/media/F-_hqtaa0AETT-I.jpg)